Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991

Molecular Pharmacology

Volumn 57, Issue 6, 2000, Pages 1218-1223

  Wang, Hong Sheng ^a   Brown, Barry S ^b   Mckinnon, David ^b   Cohen, Ira S ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART; NONHUMAN; PRIORITY JOURNAL; XENOPUS LAEVIS;

ANIMALS; ANTHRACENES; HUMANS; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; NOOTROPIC AGENTS; OOCYTES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECOMBINANT FUSION PROTEINS; XENOPUS LAEVIS;

EID: 0034082525     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann WH, Timothy KW, Keating MT and Goldstein SAN (1999) MiRP1 forms I-Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187.
2. Aiken SP, Zaczek R and Brown BS (1996) Pharmacology of the neurotransmitter release enhancer linopirdine (DuP 996), and insights into its mechanism of action, in Advances in Pharmacology (August JT, Anders MW, Murad F and Coyle JT eds) vol 35, pp 349-384, Academic Press, San Diego.
3. Ks cardiac potassium current. Nature (Lond) 384:78-80.
4. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ and Steinlein OK (1998) A potassium channel mutation in neonatal human epilepsy. Science (Wash DC) 279:403-406.
5. Brown DA. M currents (1988) in Ion Channels (Narahashi T ed) pp 55-94, New York, Plenum.
6. Busch AE, Busch GL, Ford E, Suessbrich H, Lang HJ, Greger R, Kunzelmann K, Attali B and Stuhmer W (1997) The role of the I-sK protein in the specific pharmacological properties of the I-Ks channel complex. Br J Pharmacol 122:187-189.
7. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ and Leppert M (1998) A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18:53-55.
8. Costa AMN and Brown BS (1997) Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: Mechanism of action studies. Neuropharmacology 36:1747-1753.
9. Kristufek D, Koth G, Motejlek A, Schwarz K, Huck S and Boehm S (1999) Modulation of spontaneous and stimulation-evoked transmitter release from rat sympathetic neurons by the cognition enhancer linopirdine: Insights into its mechanisms of action. J Neurochem 72:2083-2091.
10. K(M)) and some other voltage-and ligand-gated membrane currents in rat sympathetic neurons. Eur J Neurosci 9:605-616.
11. Makielski JC, Limberis JT, Chang SY, Fan Z and Kyle JW (1996) Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block. Mol Pharmacol 49:30-39.
12. Pieniaszek HJ Jr, Fiske WD, Saxton TD, Kim YS, Garner DM, Xilinas M and Martz R (1995) Single dose pharmacokinetic, safety and tolerance of linopirdine (DuP 996) in healthy young adults and elderly volunteers. J Clin Pharmacol 35:22-30.
13. Rockwood K, Beattie BL, Eastwood MR, Feldman H, Mohr E, Pryse-Phillips W and Gauthier S (1997) A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease. Can J Neural Sci 24:140-145.
14. Roden DM and George AL (1996) The cardiac ion channels: Relevance to management of arrhythmias. Annu Rev Med 47:135-148.
15. + currents. Mol Pharmacol 53:220-230.
16. Ks potassium channel. Nature (Lond) 384:80-83.
17. Schnee ME and Brown BS (1998) Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons. J Pharmacol Exp Ther 286:709-717.
18. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV, McHarg ML, Gagnon D, Rosales TO, Peiffer A, Anderson VE and Leppert M (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18:25-29.
19. Takumi T, Ohkubu H and Nakanishi S (1988) Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science (Wash DC) 242:1042-1045.
20. ta2 current. Circ Res 81:711-718.
21. Wang H-S and McKinnon D (1995) Potassium currents in rat prevertebral and paravertebral sympathetic neurones: Control of firing properties. J Physiol (Lond) 485:319-335.
22. Wang H-S, Pan ZM, Shi WM, Brown BS, Wymore RS, Cohen IS, Dixon JE and McKinnon D (1998) KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel. Science (Wash DC) 282:1890-1893.
23. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, deJager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD and Keating MT (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23.
24. Yamada WM, Koch C and Adams PR (1989) Multiple channels and calcium dynamics in Methods in Neuronal Modeling (Koch C and Segev I eds) pp 97-133, Bradford, Cambridge, MA.
25. Yang W-P, Levesque PC, Little WA, Lee Conder M, Shalaby FY and Blanar MA (1997) KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci USA 94:4017-4021.
26. Zaczek R, Chorvat RJ, Saye JA, Pierdomenico ME, Maciag CM, Logue AR, Fisher BN, Rominger DH and Earl RA (1998) Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: Comparison to linopirdine. J Pharmacol Exp Ther 285:724-730.